Universitätsklinikum Schleswig-Holstein (UKSH)

Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy (2018) Denkert C, Von Minckwitz G, Darb-Esfahani S, Lederer B, Heppner BI, Weber KE, Budczies J, et al. Journal article The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians (2018) Kähler KC, Blome C, Forschner A, Gutzmer R, Hauschild A, Heinzerling L, Livingstone E, et al. Journal article Patients' and Physicians' Preferences for Systemic Psoriasis Treatments: A Nationwide Comparative Discrete Choice Experiment (PsoCompare) (2018) Schaarschmidt ML, Herr RM, Gutknecht M, Wroblewska K, Gerdes S, Sticherling M, Augustin M, Peitsch WK Journal article Mechanisms of Autoantibody-Induced Pathology. (2017) Ludwig RJ, Vanhoorelbeke K, Leypoldt F, Kaya Z, Bieber K, Mclachlan SM, Komorowski L, et al. Journal article, Review article Checkpoint blockade for metastatic melanoma and Merkel cell carcinoma in HIV-positive patients (2017) Heppt MV, Schlaak M, Eigentler TK, Kaehler KC, Kiecker F, Loquai C, Meier F, et al. Journal article Smoking and physical inactivity increase cancer prevalence in BRCA-1 and BRCA-2 mutation carriers: results from a retrospective observational analysis (2017) Grill S, Yahiaoui-Doktor M, Dukatz R, Lammert J, Ullrich M, Engel C, Pfeifer K, et al. Journal article Feasibility of structured endurance training and Mediterranean diet in BRCA1 and BRCA2 mutation carriers - an interventional randomized controlled multicenter trial (LIBRE-1) (2017) Kiechle M, Dukatz R, Yahiaoui-Doktor M, Berling A, Basrai M, Staiger V, Niederberger U, et al. Journal article Gestational trophoblastic tumors Gestationsbedingte Trophoblasttumoren (2017) Mundhenke C Journal article, Review article Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab (2017) Brueggemann C, Kirchberger MC, Goldinger SM, Weide B, Konrad A, Erdmann M, Schadendorf D, et al. Journal article Treatment-free interval as a metric of patient experience and a health outcome of value for advanced multiple myeloma: the case for the histone deacetylase inhibitor panobinostat, a next-generation novel agent (2017) Richardson P, Roy A, Acharyya S, Panneerselvam A, Mendelson E, Guenther A, Lonial S, Einsele H Journal article